Company news
Castle Biosciences, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Castle Biosciences Announces Issuance of First U.S. Patent Covering DecisionDx-Melanoma
March 4, 2020
Castle Biosciences to Release Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Tuesday, March 10, 2020
February 24, 2020
Castle Biosciences Announces Study Establishing the Value of Integrating DecisionDx-SCC Test into Management of High-Risk Cutaneous Squamous Cell Carcinoma
January 19, 2020
Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2019 Performance Results, Delivering 29% DecisionDx-Melanoma Test Report Volume Growth in 2019
January 8, 2020
Castle Biosciences Announces Level of Evidence Review on DecisionDx-Melanoma Published in Latest Issue of American Journal of Clinical Dermatology
December 29, 2019
Castle Biosciences Announces Time Change for Presentation at the Evercore ISI Second Annual HealthCONx
December 2, 2019
Castle Biosciences Presents Expanded Data Supporting Use of DecisionDx-Melanoma Test to Inform Sentinel Lymph Node Biopsy Recommendations
November 24, 2019
Castle Biosciences Reports Third Quarter 2019 Results
November 10, 2019
Castle Biosciences Presents Clinical Validation Study for its Cutaneous Squamous Cell Carcinoma Prognostic Test at the American Society for Dermatologic Surgery (ASDS) 2019 Annual Meeting
October 28, 2019
Castle Biosciences to Release Third Quarter 2019 Financial Results and Host Conference Call on Monday, November 11, 2019
October 27, 2019
Castle Biosciences Announces Presentation of Prospective, Multicenter Study Demonstrating Significant Impact of DecisionDx-UM on Treatment Plan Recommendations for Patients with Uveal Melanoma
October 15, 2019
Castle Biosciences Added to Membership of US Small-Cap Russell 2000® Index
September 18, 2019
Calls
The 5 newest of 24 calls. Every call is listed under its year.
- Castle Biosciences (NASDAQ:CSTL) Q3 2026 Earnings Call
Nov 5, 2026
Transcript - Castle Biosciences (NASDAQ:CSTL) Q2 2026 Earnings Call
Jul 30, 2026
Transcript - Castle Biosciences (NASDAQ:CSTL) Q1 2026 Earnings Call
May 6, 2026
Transcript - Castle Biosciences (NASDAQ:CSTL) Q4 2025 Earnings Call
Feb 26, 2026
Transcript - Castle Biosciences (NASDAQ:CSTL) Q3 2025 Earnings Call
Nov 3, 2025
Transcript
Decks
The 5 newest of 56 decks. Every deck is listed under its year.
- Q3 2026 Earnings Presentation
Earnings · 32 slides · November 2026
- Q2 2026 Earnings Presentation
Earnings · 34 slides · Jul 30, 2026
- Q1 2026 Earnings Presentation
Earnings · 33 slides · May 6, 2026
- Technical Presentation (March 2026)
Technical · 29 slides · Mar 23, 2026
- Q4 2025 Earnings Presentation
Earnings · 32 slides · Feb 26, 2026